Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8+ T lymphocytes

被引:45
作者
Caccamo, N
Milano, S
Di Sano, C
Cigna, D
Ivanyi, J
Krensky, AM
Dieli, F
Salerno, A
机构
[1] Univ Palermo, Dept Biopathol, I-90134 Palermo, Italy
[2] CNR, Inst Adv Diagnost Methodol, Palermo, Italy
[3] Guys Hosp, Sch Med & Dent, Kings Coll London, Dept Oral Med & Pathol, London SE1 9RT, England
[4] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
关键词
D O I
10.1086/344174
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) T cells could make an important contribution to protection against tuberculosis (TB), but the antigenic determinants recognized in the context of major histocompatibility complex class I molecules remain ill defined. Our aim was to identify nonamer peptides derived from the acr/16-kDa antigen. Two immunogenic peptides (p21-29 and p120-128) were identified by their ability to elicit cytotoxic CD8(+) T cells from juvenile patients recovering from TB. Epitope-specific recognition was demonstrated by the lysis of both Mycobacterium tuberculosis-infected and peptide-pulsed macrophages, the release of cytotoxic granules, and interferon-gamma and tumor necrosis factor-alpha production. CD8(+) T cell responses to p21-29 and p120-128 were detected ex vivo in freshly isolated peripheral blood mononuclear cells from patients with TB but not in those from healthy control subjects. Our data suggest that these antigenic peptides can play a critical role in effective immunity against mycobacterial infection and TB.
引用
收藏
页码:991 / 998
页数:8
相关论文
共 31 条
[1]  
Agrewala JN, 1998, CLIN EXP IMMUNOL, V114, P392
[2]   Monitoring HIV-specific CD8+T cell responses by intracellular cytokine production [J].
Betts, MR ;
Casazza, JP ;
Koup, RA .
IMMUNOLOGY LETTERS, 2001, 79 (1-2) :117-125
[3]  
Canaday DH, 1999, J IMMUNOL, V162, P372
[4]   Antimicrobial activity of MHC class I-restricted CD8+T cells in human tuberculosis [J].
Cho, S ;
Mehra, V ;
Thoma-Uszynski, S ;
Stenger, S ;
Serbina, N ;
Mazzaccaro, RJ ;
Flynn, JL ;
Barnes, PF ;
Southwood, S ;
Celis, E ;
Bloom, BR ;
Modlin, RL ;
Sette, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12210-12215
[5]   Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptides [J].
da Fonseca, DPAJ ;
Joosten, D ;
van der Zee, R ;
Jue, DL ;
Singh, M ;
Vordermeier, HM ;
Snippe, H ;
Verheul, AFM .
INFECTION AND IMMUNITY, 1998, 66 (07) :3190-3197
[6]  
DELIBERO G, 1988, EUR J IMMUNOL, V18, P59, DOI 10.1002/eji.1830180110
[7]  
Dieli F, 2000, SCAND J IMMUNOL, V52, P96
[8]   Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vγ9/Vδ2 T lymphocytes [J].
Dieli, F ;
Troye-Blomberg, M ;
Ivanyi, J ;
Fournié, JJ ;
Krensky, AM ;
Bonneville, M ;
Peyrat, MA ;
Caccamo, N ;
Sireci, G ;
Salerno, A .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :1082-1085
[9]   Granulysin, a T cell product, kills bacteria by altering membrane permeability [J].
Ernst, WA ;
Thoma-Uszynski, S ;
Teitelbaum, P ;
Ko, C ;
Hanson, DA ;
Clayberger, C ;
Krensky, AM ;
Leippe, M ;
Bloom, BR ;
Ganz, T ;
Modlin, RL .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :7102-7108
[10]   Immunology of tuberculosis [J].
Flynn, JL ;
Chan, J .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :93-129